AirSculpt Technologies (AIRS) Registration Filing summary

Company overview and business model

• Operates a network of 32 centers in the U.S., Canada, and the UK, offering minimally invasive body contouring procedures using proprietary technology, with all services provided on a 100% private pay, upfront basis.

• Offers a range of fat removal and fat transfer procedures, including innovative treatments like Power BBL®, Up a Cup™, and Hip Flip™, and has expanded into skin tightening and cellulite reduction.

• Utilizes digital marketing, influencer endorsements, and a premium patient experience to drive brand recognition and patient acquisition.

• All clinical operations are managed by professional associations owned by surgeons, while the company provides non-clinical management services.

Financial performance and metrics

• Generated $180.4 million in revenue for the year ended December 31, 2024, a 7.9% decline from $195.9 million in 2023.

• Performed 14,036 body contouring procedures in 2024.

• Implemented a cost reduction program expected to eliminate approximately $3 million in annual overhead and contracted expenses.

Use of proceeds and capital allocation

• Net proceeds from securities sales will be used for general corporate purposes, including working capital, acquisitions, retirement of debt, and other business opportunities.

• Management has broad discretion over the timing and application of proceeds, which may be temporarily invested in capital preservation instruments.